Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Jui Ho

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|February 15, 2022
Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variantsFrancisco J Sánchez-Rivera, Bianca J Diaz, Edward R Kastenhuber, et al.
Science (New York, N.Y.)|May 11, 2023
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesisCassandra Burdziak, Direna Alonso-Curbelo, Thomas Walle, et al.
Nature Cancer|September 25, 2025
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residenceKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesisJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
Cell|April 16, 2026
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transitionJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Discovery|October 20, 2022
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL InhibitionYadira M Soto-Feliciano, Francisco J Sánchez-Rivera, Florian Perner, et al.
The Journal of Clinical Investigation|September 15, 2022
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockadeArnab Ghosh, Judith Michels, Riccardo Mezzadra, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|February 15, 2022
Base editing sensor libraries for high-throughput engineering and functional analysis of cancer-associated single nucleotide variantsFrancisco J Sánchez-Rivera, Bianca J Diaz, Edward R Kastenhuber, et al.
Science (New York, N.Y.)|May 11, 2023
Epigenetic plasticity cooperates with cell-cell interactions to direct pancreatic tumorigenesisCassandra Burdziak, Direna Alonso-Curbelo, Thomas Walle, et al.
Nature Cancer|September 25, 2025
SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residenceKaloyan M Tsanov, Francisco M Barriga, Yu-Jui Ho, et al.
Cell|December 25, 2018
p53 Represses the Mevalonate Pathway to Mediate Tumor SuppressionSung-Hwan Moon, Chun-Hao Huang, Shauna L Houlihan, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Oncogenic and tumor-suppressive forces converge on a progenitor-orchestrated niche to shape early tumorigenesisJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Discovery|May 8, 2020
Somatic Tissue Engineering in Mouse Models Reveals an Actionable Role for WNT Pathway Alterations in Prostate Cancer MetastasisJosef Leibold, Marcus Ruscetti, Zhen Cao, et al.
Cell|April 16, 2026
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transitionJosé Reyes, Isabella Del Priore, Andrea C Chaikovsky, et al.
Cancer Discovery|October 20, 2022
A Molecular Switch between Mammalian MLL Complexes Dictates Response to Menin-MLL InhibitionYadira M Soto-Feliciano, Francisco J Sánchez-Rivera, Florian Perner, et al.
The Journal of Clinical Investigation|September 15, 2022
Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockadeArnab Ghosh, Judith Michels, Riccardo Mezzadra, et al.
Nature Cancer|January 6, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potencyPhilip Bucher, Nadine Brückner, Jule Kortendieck, et al.
Pageof 7